Area of research
Dermatology · Pathology and Forensic Medicine
Research interest
Research interests include Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment, Cutaneous Melanoma Detection and Management, and Melanoma and MAPK Pathways.
European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748
Perifollicular linear projections: A dermatoscopic criterion for the diagnosis of lentigo maligna on the face
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response
Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping
Updates from the central pathology review in patients with advanced stage mycosis fungoides (MF) and Sezary syndrome (SS) for the Global PROCLIPI study
Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas
<scp>ALK</scp>‐positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature
Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors
Primary cutaneous B-cell lymphomas
Primary cutaneous B-cell lymphomas
Immunohistochemical Analysis of BRAFV600E Expression of Primary and Metastatic Melanoma and Comparison With Mutation Status and Melanocyte Differentiation Antigens of Metastatic Lesions